293 related articles for article (PubMed ID: 32583173)
1. Treatment Options for MODY Patients: A Systematic Review of Literature.
Delvecchio M; Pastore C; Giordano P
Diabetes Ther; 2020 Aug; 11(8):1667-1685. PubMed ID: 32583173
[TBL] [Abstract][Full Text] [Related]
2. Maturity-Onset Diabetes of the Young (MODY) in Portugal: Novel
Alvelos MI; Gonçalves CI; Coutinho E; Almeida JT; Bastos M; Sampaio ML; Melo M; Martins S; Dinis I; Mirante A; Gomes L; Saraiva J; Pereira BD; Gama-de-Sousa S; Moreno C; Guelho D; Martins D; Baptista C; Barros L; Ventura M; Gomes MM; Lemos MC
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31968686
[TBL] [Abstract][Full Text] [Related]
3. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
4. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin.
Shepherd MH; Shields BM; Hudson M; Pearson ER; Hyde C; Ellard S; Hattersley AT; Patel KA;
Diabetologia; 2018 Dec; 61(12):2520-2527. PubMed ID: 30229274
[TBL] [Abstract][Full Text] [Related]
5. Management of pregnancy in women with monogenic diabetes due to mutations in
Crowley MT; Paponette B; Bacon S; Byrne MM
Front Genet; 2024; 15():1362977. PubMed ID: 38933924
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, clinical features and complications of common forms of Maturity Onset Diabetes of the Young (MODY) seen at a tertiary diabetes centre in south India.
Aarthy R; Aston-Mourney K; Amutha A; Mikocka-Walus A; Anjana RM; Unnikrishnan R; Jebarani S; Venkatesan U; Gopi S; Radha V; Mohan V
Prim Care Diabetes; 2023 Aug; 17(4):401-407. PubMed ID: 37055265
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Analysis of Hungarian MODY Patients-Part I: Gene Panel Sequencing Reveals Pathogenic Mutations in
Gaál Z; Szűcs Z; Kántor I; Luczay A; Tóth-Heyn P; Benn O; Felszeghy E; Karádi Z; Madar L; Balogh I
Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440499
[TBL] [Abstract][Full Text] [Related]
8. A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY.
Bishay RH; Greenfield JR
Med J Aust; 2016 Nov; 205(10):480-485. PubMed ID: 27852188
[TBL] [Abstract][Full Text] [Related]
9. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
[TBL] [Abstract][Full Text] [Related]
10. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L
Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271
[TBL] [Abstract][Full Text] [Related]
11. Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: A systemic review and meta-analysis.
Liu J; Xiao X; Zhang Q; Yu M
J Diabetes; 2023 Jun; 15(6):519-531. PubMed ID: 37226652
[TBL] [Abstract][Full Text] [Related]
12. HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey.
Beysel S; Eyerci N; Pinarli FA; Kizilgul M; Ozcelik O; Caliskan M; Cakal E
BMC Endocr Disord; 2019 May; 19(1):51. PubMed ID: 31109344
[TBL] [Abstract][Full Text] [Related]
13. Quality of life assessment in patients with HNF1A-MODY and GCK-MODY.
Szopa M; Matejko B; Ucieklak D; Uchman A; Hohendorff J; Mrozińska S; Głodzik W; Zapała B; Płatek T; Solecka I; Sani CM; Małecki MT
Endocrine; 2019 May; 64(2):246-253. PubMed ID: 30421137
[TBL] [Abstract][Full Text] [Related]
14. Maturity-onset diabetes of the young (MODY): an update.
Anık A; Çatlı G; Abacı A; Böber E
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):251-63. PubMed ID: 25581748
[TBL] [Abstract][Full Text] [Related]
15. Maturity onset diabetes of the young: Seek and you will find.
Heuvel-Borsboom H; de Valk HW; Losekoot M; Westerink J
Neth J Med; 2016 Jun; 74(5):193-200. PubMed ID: 27323672
[TBL] [Abstract][Full Text] [Related]
16. [Current treatment options in Maturity-Onset Diabetes of the Young].
Brunerová L; Urbanová J; Brož J
Vnitr Lek; 2018; 64(4):375-379. PubMed ID: 29791172
[TBL] [Abstract][Full Text] [Related]
17. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.
Pal A; Farmer AJ; Dudley C; Selwood MP; Barrow BA; Klyne R; Grew JP; McCarthy MI; Gloyn AL; Owen KR
Diabetes Care; 2010 Feb; 33(2):252-7. PubMed ID: 19933992
[TBL] [Abstract][Full Text] [Related]
19. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed.
Stanik J; Dusatkova P; Cinek O; Valentinova L; Huckova M; Skopkova M; Dusatkova L; Stanikova D; Pura M; Klimes I; Lebl J; Gasperikova D; Pruhova S
Diabetologia; 2014 Mar; 57(3):480-4. PubMed ID: 24323243
[TBL] [Abstract][Full Text] [Related]
20. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes.
Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D
J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
